Skip to main content
Tech.euFundingExplorerBeta

AstriVax

KU Leuven spin-off that develops vaccines

AstriVax has raised €33M across 2 funding rounds from 9 investors, most recently a Grant round in May 2023. Based in Leuven, Belgium; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€33M
€32,500,000
Funding rounds
2
Investors
9
distinct backers
Active since
2022-08
latest 2023-05

Funding by year

EUR raised per year
AstriVax — funding by year — interactive chart.
Data table
AstriVax — funding by year
2022€30M
2023€2.5M

Signals

High confidence
Raise-next likelihood7
base rate 45% for Grant
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Related news

Similar companies

same sector or country

Global coverage: FundingData